user/markdrussell/psoriatic-arthritis/6c69f57e
user/markdrussell/axial-spondyloarthritis/057968b4 
user/markdrussell/new-rheumatoid-arthritis/535a8249 
user/markdrussell/undiff-eia/459a5829
user/markdrussell/referral-rheumatology/6bc8e5e3
opensafely/cancer-excluding-lung-and-haematological/2020-04-15
opensafely/chronic-cardiac-disease/2020-04-08
opensafely/chronic-liver-disease/2020-06-02
opensafely/chronic-kidney-disease/2020-04-14
opensafely/chronic-respiratory-disease/2020-04-10
opensafely/crohns-disease/223a39f5
opensafely/current-copd/2020-05-06
opensafely/diabetes/2020-04-15
opensafely/dmards/2020-06-23
opensafely/ethnicity/2020-04-27
opensafely/haematological-cancer/2020-04-15
opensafely/hypertension/2020-04-28
opensafely/lung-cancer/2020-04-15
opensafely/smoking-clear/2020-04-29
opensafely/smoking-unclear/2020-04-29
opensafely/solid-organ-transplantation/2020-04-10
opensafely/stroke-updated/2020-06-02
opensafely/high-cost-drugs-abatacept/07fc04eb
opensafely/high-cost-drugs-adalimumab/6eec91b5
opensafely/high-cost-drugs-baricitinib/0aaec4e1
opensafely/high-cost-drugs-certolizumab/2670f80c
opensafely/high-cost-drugs-etanercept/0d6184d7
opensafely/high-cost-drugs-golimumab/745211a1
opensafely/high-cost-drugs-guselkumab/5b429e6c
opensafely/high-cost-drugs-infliximab/42332b37
opensafely/high-cost-drugs-ixekizumab/2923b802
opensafely/high-cost-drugs-methotrexate/70d89e1c
opensafely/high-cost-drugs-rituximab/57c92ae7
opensafely/high-cost-drugs-sarilumab/2e8937ee
opensafely/high-cost-drugs-secukinumab/1579c4b9
opensafely/high-cost-drugs-tocilizumab/635ade4e
opensafely/high-cost-drugs-tofacitinib/4a4b6b19
opensafely/high-cost-drugs-upadacitinib/313bf7e4
opensafely/high-cost-drugs-ustekinumab/182c84af
opensafely/hydroxychloroquine/4c53b277
opensafely/leflunomide-dmd/1765d120
opensafely/methotrexate-injectable/3328044b
opensafely/methotrexate-oral/041a8320
opensafely/sulfasalazine-oral-dmd/1a189116